Developing next-generation NK cell and innate lymphoid cell therapeutics for oncology and auto-immune disease. By utilizing highly innovative macrocyclic multi-specific cell engagers, Nickl aims to redirect the cytotoxic capabilities of NK cells for the precision killing of disease mediating cells across a number of therapeutic settings.
Initial focus is on the activation of the innate immune system within the microenvironment of solid tumors to enhance cancer cell killing and provide improved patient outcomes in indications with significant unmet need.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Sagamore Beach.
Nickl Therapeutics Questions
Nickl Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nickl-therapeutics
Nickl Therapeutics has
1 employees.
View email and phone details for 1
employees at Nickl Therapeutics.
Nickl Therapeutics's industry is
Biotechnology Research
Nickl Therapeutics's top competitors are
General Inception,
Aleta Biotherapeutics,
Servpro Of Upper Cape Cod & The Islands,
Ennovate Pharma,
Preciphos,
Brooklyness Australia,
Orthomaster,
Inspr,
Headlight,
Tekimpact.
Nickl Therapeutics's categories are Biotechnology Research
Nickl Therapeutics's founding year is 2023
